2024 Regulatory Outlook With Dr. Peter Marks And Dr. Nicole Verdun | Audience Q&A
In this segment, Dr. Peter Marks and Dr. Nicole Verdun spent some time answering questions from the audience. They provided detailed responses on topics including pediatric development in rare disease, diversity planning for ultra rare disease, anticipated approvals by 2025 and more.
access the Video!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.
Subscribe to Cell & Gene
X
Subscribe to Cell & Gene
Thermo Fisher Scientific Bioproduction
This website uses cookies to ensure you get the best experience on our website. Learn more